Loading…

Living Related Donor Liver Transplantation in Children

Abstract Objective The objective of this study was to report our experience with pediatric orthotopic liver transplantation (OLT) with living related donors. Methods We performed a retrospective chart analysis of 121 living related donor liver transplantations (LRDLT) from June 1998 to June 2010. Re...

Full description

Saved in:
Bibliographic Details
Published in:Transplantation proceedings 2011, Vol.43 (1), p.161-164
Main Authors: Tannuri, A.C.A, Gibelli, N.E.M, Ricardi, L.R.S, Santos, M.M, Maksoud-Filho, J.G, Pinho-Apezzato, M.L, Silva, M.M, Velhote, M.C.P, Ayoub, A.A.R, Andrade, W.C, Leal, A.J, Miyatani, H.T, Tannuri, U
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c464t-92a61316bc9164cdbdeb1684504d014e84a8a3ae4ca450ba2d1473ea60d4ef293
cites cdi_FETCH-LOGICAL-c464t-92a61316bc9164cdbdeb1684504d014e84a8a3ae4ca450ba2d1473ea60d4ef293
container_end_page 164
container_issue 1
container_start_page 161
container_title Transplantation proceedings
container_volume 43
creator Tannuri, A.C.A
Gibelli, N.E.M
Ricardi, L.R.S
Santos, M.M
Maksoud-Filho, J.G
Pinho-Apezzato, M.L
Silva, M.M
Velhote, M.C.P
Ayoub, A.A.R
Andrade, W.C
Leal, A.J
Miyatani, H.T
Tannuri, U
description Abstract Objective The objective of this study was to report our experience with pediatric orthotopic liver transplantation (OLT) with living related donors. Methods We performed a retrospective chart analysis of 121 living related donor liver transplantations (LRDLT) from June 1998 to June 2010. Results Indications were biliary atresia (BA; n = 81), primary sclerosing cholangitis (n = 5), α-1 antitrypsin deficiency (n = 4); cholestasis (n = 9), fulminant hepatic failure (n = 8), autoimmune hepatitis (n = 2), Alagille syndrome (n = 4), hepatoblastoma (n = 3), tyrosinemia (n = 2), and congenital hepatic fibrosis (n = 3). The age of the recipients ranged from 7–174 months (median, 22) and the weights ranged from 6–58 kg (median, 10). Forty-nine children (40.5%) weighed ≤10 kg. The grafts included the left lateral segment (n = 108), the left lobe (n = 12), and the right lobe (n = 1). The donors included 71 mothers, 45 fathers, 2 uncles, 1 grandmother, 1 grandfather, and 1 sister with a median age of 29 years (range, 16–53 ys) and a median weight of 68 kg (range, 47–106). Sixteen patients (12.9%) required retransplantation, most commonly due to hepatic artery thrombosis (HAT; n = 13; 10.7%). The other complications were biliary stenosis (n = 25; 20.6%), portal vein thrombosis (PVT; n = 11; 9.1%), portal vein stenosis (n = 5; 4.1%), hepatic vein stenosis (n = 6; 4.9%), and lymphoproliferative disorders (n = 8; 6.6%). The ultimate survival rate of recipients was 90.3% after 1 year and 75.8% after 3 years. Causes of early death within 1 month were HAT (n = 6), PVT (n = 2), severe graft dysfunction (n = 1), sepsis (n = 1), and intraoperative death in children with acute liver failure (n = 2). Causes of late deaths included lymphoproliferative disease (n = 3), chronic rejection (n = 2), biliary complications (n = 3), and recurrent disease (n = 3; hepatoblastoma and primary sclerosing cholangitis). Conclusions Despite the heightened possibility of complications (mainly vascular), LRDLT represented a good alternative to transplantation from cadaveric donors in pediatric populations. It was associated with a high survival ratio.
doi_str_mv 10.1016/j.transproceed.2010.11.013
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_853472384</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>1_s2_0_S0041134510017203</els_id><sourcerecordid>853472384</sourcerecordid><originalsourceid>FETCH-LOGICAL-c464t-92a61316bc9164cdbdeb1684504d014e84a8a3ae4ca450ba2d1473ea60d4ef293</originalsourceid><addsrcrecordid>eNqNkU1rGzEQQEVpqR23fyEsgZLTuhpJ1so5FIKTtAVDIHHPQiuNEzlrrSutA_730dY2CT3lJKR586E3hJwBHQMF-X017qIJaRNbi-jGjPYBGFPgH8gQVMVLJhn_SIaUCiiBi8mAnKS0ovnOBP9MBgw4n0BVDYmc-2cfHoo7bEyHrrhqQxuL_IixWPzr0pjQmc63ofChmD36xkUMX8inpWkSfj2cI_Ln5nox-1XOb3_-nl3OSyuk6MopMxI4yNpOQQrraoc1SCUmVDgKApUwynCDwpr8VhvmQFQcjaRO4JJN-Yic7-vmz_7dYur02ieLTR4K223SasJFxbgSmbzYkza2KUVc6k30axN3GqjutemVfqtN99o0gM7acvLpoc22XufYMfXoKQPfDoBJ1jTLXMj69MpxNaVK9dzVnsMs5dlj1Ml6DBadj2g77Vr_vnl-_FfGNj743PkJd5hW7TaGrF2DTkxTfd8vut8zUAoVo5y_AP4xpgA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>853472384</pqid></control><display><type>article</type><title>Living Related Donor Liver Transplantation in Children</title><source>ScienceDirect Journals</source><creator>Tannuri, A.C.A ; Gibelli, N.E.M ; Ricardi, L.R.S ; Santos, M.M ; Maksoud-Filho, J.G ; Pinho-Apezzato, M.L ; Silva, M.M ; Velhote, M.C.P ; Ayoub, A.A.R ; Andrade, W.C ; Leal, A.J ; Miyatani, H.T ; Tannuri, U</creator><creatorcontrib>Tannuri, A.C.A ; Gibelli, N.E.M ; Ricardi, L.R.S ; Santos, M.M ; Maksoud-Filho, J.G ; Pinho-Apezzato, M.L ; Silva, M.M ; Velhote, M.C.P ; Ayoub, A.A.R ; Andrade, W.C ; Leal, A.J ; Miyatani, H.T ; Tannuri, U</creatorcontrib><description>Abstract Objective The objective of this study was to report our experience with pediatric orthotopic liver transplantation (OLT) with living related donors. Methods We performed a retrospective chart analysis of 121 living related donor liver transplantations (LRDLT) from June 1998 to June 2010. Results Indications were biliary atresia (BA; n = 81), primary sclerosing cholangitis (n = 5), α-1 antitrypsin deficiency (n = 4); cholestasis (n = 9), fulminant hepatic failure (n = 8), autoimmune hepatitis (n = 2), Alagille syndrome (n = 4), hepatoblastoma (n = 3), tyrosinemia (n = 2), and congenital hepatic fibrosis (n = 3). The age of the recipients ranged from 7–174 months (median, 22) and the weights ranged from 6–58 kg (median, 10). Forty-nine children (40.5%) weighed ≤10 kg. The grafts included the left lateral segment (n = 108), the left lobe (n = 12), and the right lobe (n = 1). The donors included 71 mothers, 45 fathers, 2 uncles, 1 grandmother, 1 grandfather, and 1 sister with a median age of 29 years (range, 16–53 ys) and a median weight of 68 kg (range, 47–106). Sixteen patients (12.9%) required retransplantation, most commonly due to hepatic artery thrombosis (HAT; n = 13; 10.7%). The other complications were biliary stenosis (n = 25; 20.6%), portal vein thrombosis (PVT; n = 11; 9.1%), portal vein stenosis (n = 5; 4.1%), hepatic vein stenosis (n = 6; 4.9%), and lymphoproliferative disorders (n = 8; 6.6%). The ultimate survival rate of recipients was 90.3% after 1 year and 75.8% after 3 years. Causes of early death within 1 month were HAT (n = 6), PVT (n = 2), severe graft dysfunction (n = 1), sepsis (n = 1), and intraoperative death in children with acute liver failure (n = 2). Causes of late deaths included lymphoproliferative disease (n = 3), chronic rejection (n = 2), biliary complications (n = 3), and recurrent disease (n = 3; hepatoblastoma and primary sclerosing cholangitis). Conclusions Despite the heightened possibility of complications (mainly vascular), LRDLT represented a good alternative to transplantation from cadaveric donors in pediatric populations. It was associated with a high survival ratio.</description><identifier>ISSN: 0041-1345</identifier><identifier>EISSN: 1873-2623</identifier><identifier>DOI: 10.1016/j.transproceed.2010.11.013</identifier><identifier>PMID: 21335177</identifier><identifier>CODEN: TRPPA8</identifier><language>eng</language><publisher>Amsterdam: Elsevier Inc</publisher><subject>Adolescent ; Adult ; Biological and medical sciences ; Child ; Family ; Female ; Fundamental and applied biological sciences. Psychology ; Fundamental immunology ; General aspects ; Humans ; Immunosuppressive Agents - administration &amp; dosage ; Liver Transplantation ; Liver, biliary tract, pancreas, portal circulation, spleen ; Living Donors ; Male ; Medical sciences ; Middle Aged ; Retrospective Studies ; Surgery ; Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases ; Surgery of the digestive system ; Tissue, organ and graft immunology</subject><ispartof>Transplantation proceedings, 2011, Vol.43 (1), p.161-164</ispartof><rights>Elsevier Inc.</rights><rights>2011 Elsevier Inc.</rights><rights>2015 INIST-CNRS</rights><rights>Copyright © 2011 Elsevier Inc. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c464t-92a61316bc9164cdbdeb1684504d014e84a8a3ae4ca450ba2d1473ea60d4ef293</citedby><cites>FETCH-LOGICAL-c464t-92a61316bc9164cdbdeb1684504d014e84a8a3ae4ca450ba2d1473ea60d4ef293</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>309,310,314,780,784,789,790,4024,4050,4051,23930,23931,25140,27923,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=23890887$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/21335177$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Tannuri, A.C.A</creatorcontrib><creatorcontrib>Gibelli, N.E.M</creatorcontrib><creatorcontrib>Ricardi, L.R.S</creatorcontrib><creatorcontrib>Santos, M.M</creatorcontrib><creatorcontrib>Maksoud-Filho, J.G</creatorcontrib><creatorcontrib>Pinho-Apezzato, M.L</creatorcontrib><creatorcontrib>Silva, M.M</creatorcontrib><creatorcontrib>Velhote, M.C.P</creatorcontrib><creatorcontrib>Ayoub, A.A.R</creatorcontrib><creatorcontrib>Andrade, W.C</creatorcontrib><creatorcontrib>Leal, A.J</creatorcontrib><creatorcontrib>Miyatani, H.T</creatorcontrib><creatorcontrib>Tannuri, U</creatorcontrib><title>Living Related Donor Liver Transplantation in Children</title><title>Transplantation proceedings</title><addtitle>Transplant Proc</addtitle><description>Abstract Objective The objective of this study was to report our experience with pediatric orthotopic liver transplantation (OLT) with living related donors. Methods We performed a retrospective chart analysis of 121 living related donor liver transplantations (LRDLT) from June 1998 to June 2010. Results Indications were biliary atresia (BA; n = 81), primary sclerosing cholangitis (n = 5), α-1 antitrypsin deficiency (n = 4); cholestasis (n = 9), fulminant hepatic failure (n = 8), autoimmune hepatitis (n = 2), Alagille syndrome (n = 4), hepatoblastoma (n = 3), tyrosinemia (n = 2), and congenital hepatic fibrosis (n = 3). The age of the recipients ranged from 7–174 months (median, 22) and the weights ranged from 6–58 kg (median, 10). Forty-nine children (40.5%) weighed ≤10 kg. The grafts included the left lateral segment (n = 108), the left lobe (n = 12), and the right lobe (n = 1). The donors included 71 mothers, 45 fathers, 2 uncles, 1 grandmother, 1 grandfather, and 1 sister with a median age of 29 years (range, 16–53 ys) and a median weight of 68 kg (range, 47–106). Sixteen patients (12.9%) required retransplantation, most commonly due to hepatic artery thrombosis (HAT; n = 13; 10.7%). The other complications were biliary stenosis (n = 25; 20.6%), portal vein thrombosis (PVT; n = 11; 9.1%), portal vein stenosis (n = 5; 4.1%), hepatic vein stenosis (n = 6; 4.9%), and lymphoproliferative disorders (n = 8; 6.6%). The ultimate survival rate of recipients was 90.3% after 1 year and 75.8% after 3 years. Causes of early death within 1 month were HAT (n = 6), PVT (n = 2), severe graft dysfunction (n = 1), sepsis (n = 1), and intraoperative death in children with acute liver failure (n = 2). Causes of late deaths included lymphoproliferative disease (n = 3), chronic rejection (n = 2), biliary complications (n = 3), and recurrent disease (n = 3; hepatoblastoma and primary sclerosing cholangitis). Conclusions Despite the heightened possibility of complications (mainly vascular), LRDLT represented a good alternative to transplantation from cadaveric donors in pediatric populations. It was associated with a high survival ratio.</description><subject>Adolescent</subject><subject>Adult</subject><subject>Biological and medical sciences</subject><subject>Child</subject><subject>Family</subject><subject>Female</subject><subject>Fundamental and applied biological sciences. Psychology</subject><subject>Fundamental immunology</subject><subject>General aspects</subject><subject>Humans</subject><subject>Immunosuppressive Agents - administration &amp; dosage</subject><subject>Liver Transplantation</subject><subject>Liver, biliary tract, pancreas, portal circulation, spleen</subject><subject>Living Donors</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Retrospective Studies</subject><subject>Surgery</subject><subject>Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases</subject><subject>Surgery of the digestive system</subject><subject>Tissue, organ and graft immunology</subject><issn>0041-1345</issn><issn>1873-2623</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2011</creationdate><recordtype>article</recordtype><recordid>eNqNkU1rGzEQQEVpqR23fyEsgZLTuhpJ1so5FIKTtAVDIHHPQiuNEzlrrSutA_730dY2CT3lJKR586E3hJwBHQMF-X017qIJaRNbi-jGjPYBGFPgH8gQVMVLJhn_SIaUCiiBi8mAnKS0ovnOBP9MBgw4n0BVDYmc-2cfHoo7bEyHrrhqQxuL_IixWPzr0pjQmc63ofChmD36xkUMX8inpWkSfj2cI_Ln5nox-1XOb3_-nl3OSyuk6MopMxI4yNpOQQrraoc1SCUmVDgKApUwynCDwpr8VhvmQFQcjaRO4JJN-Yic7-vmz_7dYur02ieLTR4K223SasJFxbgSmbzYkza2KUVc6k30axN3GqjutemVfqtN99o0gM7acvLpoc22XufYMfXoKQPfDoBJ1jTLXMj69MpxNaVK9dzVnsMs5dlj1Ml6DBadj2g77Vr_vnl-_FfGNj743PkJd5hW7TaGrF2DTkxTfd8vut8zUAoVo5y_AP4xpgA</recordid><startdate>2011</startdate><enddate>2011</enddate><creator>Tannuri, A.C.A</creator><creator>Gibelli, N.E.M</creator><creator>Ricardi, L.R.S</creator><creator>Santos, M.M</creator><creator>Maksoud-Filho, J.G</creator><creator>Pinho-Apezzato, M.L</creator><creator>Silva, M.M</creator><creator>Velhote, M.C.P</creator><creator>Ayoub, A.A.R</creator><creator>Andrade, W.C</creator><creator>Leal, A.J</creator><creator>Miyatani, H.T</creator><creator>Tannuri, U</creator><general>Elsevier Inc</general><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>2011</creationdate><title>Living Related Donor Liver Transplantation in Children</title><author>Tannuri, A.C.A ; Gibelli, N.E.M ; Ricardi, L.R.S ; Santos, M.M ; Maksoud-Filho, J.G ; Pinho-Apezzato, M.L ; Silva, M.M ; Velhote, M.C.P ; Ayoub, A.A.R ; Andrade, W.C ; Leal, A.J ; Miyatani, H.T ; Tannuri, U</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c464t-92a61316bc9164cdbdeb1684504d014e84a8a3ae4ca450ba2d1473ea60d4ef293</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2011</creationdate><topic>Adolescent</topic><topic>Adult</topic><topic>Biological and medical sciences</topic><topic>Child</topic><topic>Family</topic><topic>Female</topic><topic>Fundamental and applied biological sciences. Psychology</topic><topic>Fundamental immunology</topic><topic>General aspects</topic><topic>Humans</topic><topic>Immunosuppressive Agents - administration &amp; dosage</topic><topic>Liver Transplantation</topic><topic>Liver, biliary tract, pancreas, portal circulation, spleen</topic><topic>Living Donors</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Retrospective Studies</topic><topic>Surgery</topic><topic>Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases</topic><topic>Surgery of the digestive system</topic><topic>Tissue, organ and graft immunology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Tannuri, A.C.A</creatorcontrib><creatorcontrib>Gibelli, N.E.M</creatorcontrib><creatorcontrib>Ricardi, L.R.S</creatorcontrib><creatorcontrib>Santos, M.M</creatorcontrib><creatorcontrib>Maksoud-Filho, J.G</creatorcontrib><creatorcontrib>Pinho-Apezzato, M.L</creatorcontrib><creatorcontrib>Silva, M.M</creatorcontrib><creatorcontrib>Velhote, M.C.P</creatorcontrib><creatorcontrib>Ayoub, A.A.R</creatorcontrib><creatorcontrib>Andrade, W.C</creatorcontrib><creatorcontrib>Leal, A.J</creatorcontrib><creatorcontrib>Miyatani, H.T</creatorcontrib><creatorcontrib>Tannuri, U</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Transplantation proceedings</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Tannuri, A.C.A</au><au>Gibelli, N.E.M</au><au>Ricardi, L.R.S</au><au>Santos, M.M</au><au>Maksoud-Filho, J.G</au><au>Pinho-Apezzato, M.L</au><au>Silva, M.M</au><au>Velhote, M.C.P</au><au>Ayoub, A.A.R</au><au>Andrade, W.C</au><au>Leal, A.J</au><au>Miyatani, H.T</au><au>Tannuri, U</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Living Related Donor Liver Transplantation in Children</atitle><jtitle>Transplantation proceedings</jtitle><addtitle>Transplant Proc</addtitle><date>2011</date><risdate>2011</risdate><volume>43</volume><issue>1</issue><spage>161</spage><epage>164</epage><pages>161-164</pages><issn>0041-1345</issn><eissn>1873-2623</eissn><coden>TRPPA8</coden><abstract>Abstract Objective The objective of this study was to report our experience with pediatric orthotopic liver transplantation (OLT) with living related donors. Methods We performed a retrospective chart analysis of 121 living related donor liver transplantations (LRDLT) from June 1998 to June 2010. Results Indications were biliary atresia (BA; n = 81), primary sclerosing cholangitis (n = 5), α-1 antitrypsin deficiency (n = 4); cholestasis (n = 9), fulminant hepatic failure (n = 8), autoimmune hepatitis (n = 2), Alagille syndrome (n = 4), hepatoblastoma (n = 3), tyrosinemia (n = 2), and congenital hepatic fibrosis (n = 3). The age of the recipients ranged from 7–174 months (median, 22) and the weights ranged from 6–58 kg (median, 10). Forty-nine children (40.5%) weighed ≤10 kg. The grafts included the left lateral segment (n = 108), the left lobe (n = 12), and the right lobe (n = 1). The donors included 71 mothers, 45 fathers, 2 uncles, 1 grandmother, 1 grandfather, and 1 sister with a median age of 29 years (range, 16–53 ys) and a median weight of 68 kg (range, 47–106). Sixteen patients (12.9%) required retransplantation, most commonly due to hepatic artery thrombosis (HAT; n = 13; 10.7%). The other complications were biliary stenosis (n = 25; 20.6%), portal vein thrombosis (PVT; n = 11; 9.1%), portal vein stenosis (n = 5; 4.1%), hepatic vein stenosis (n = 6; 4.9%), and lymphoproliferative disorders (n = 8; 6.6%). The ultimate survival rate of recipients was 90.3% after 1 year and 75.8% after 3 years. Causes of early death within 1 month were HAT (n = 6), PVT (n = 2), severe graft dysfunction (n = 1), sepsis (n = 1), and intraoperative death in children with acute liver failure (n = 2). Causes of late deaths included lymphoproliferative disease (n = 3), chronic rejection (n = 2), biliary complications (n = 3), and recurrent disease (n = 3; hepatoblastoma and primary sclerosing cholangitis). Conclusions Despite the heightened possibility of complications (mainly vascular), LRDLT represented a good alternative to transplantation from cadaveric donors in pediatric populations. It was associated with a high survival ratio.</abstract><cop>Amsterdam</cop><pub>Elsevier Inc</pub><pmid>21335177</pmid><doi>10.1016/j.transproceed.2010.11.013</doi><tpages>4</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0041-1345
ispartof Transplantation proceedings, 2011, Vol.43 (1), p.161-164
issn 0041-1345
1873-2623
language eng
recordid cdi_proquest_miscellaneous_853472384
source ScienceDirect Journals
subjects Adolescent
Adult
Biological and medical sciences
Child
Family
Female
Fundamental and applied biological sciences. Psychology
Fundamental immunology
General aspects
Humans
Immunosuppressive Agents - administration & dosage
Liver Transplantation
Liver, biliary tract, pancreas, portal circulation, spleen
Living Donors
Male
Medical sciences
Middle Aged
Retrospective Studies
Surgery
Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases
Surgery of the digestive system
Tissue, organ and graft immunology
title Living Related Donor Liver Transplantation in Children
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-22T21%3A04%3A23IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Living%20Related%20Donor%20Liver%20Transplantation%20in%20Children&rft.jtitle=Transplantation%20proceedings&rft.au=Tannuri,%20A.C.A&rft.date=2011&rft.volume=43&rft.issue=1&rft.spage=161&rft.epage=164&rft.pages=161-164&rft.issn=0041-1345&rft.eissn=1873-2623&rft.coden=TRPPA8&rft_id=info:doi/10.1016/j.transproceed.2010.11.013&rft_dat=%3Cproquest_cross%3E853472384%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c464t-92a61316bc9164cdbdeb1684504d014e84a8a3ae4ca450ba2d1473ea60d4ef293%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=853472384&rft_id=info:pmid/21335177&rfr_iscdi=true